Alison Paterson

Alison Paterson

Company: Monte Rosa Therapeutics

Job title: Vice President, Discovery Biology,


Exploring Novel Modalities: Disabling the NLRP3 Inflammasome with a NEK7 Molecular Glue Degrader 10:30 am

Utilizing a NEK7 molecular glue degrader (MGD) as a potent and selective approach to targeting the NLRP3 inflammasome Path to the clinic with a NEK7 MGD NEK7 MGDs have tuneable tissue distribution profiles and can be highly brain penetrantRead more

day: Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.